Total Treatment Pharmaceuticals' technology stabilizes peptides and proteins. Our initial focus is stabilizing aqueous glucagon. With stable liquid glucagon, TTP provides a more effective solution for severe hypoglycemia with autoinjection and enables the artificial pancreas. With prompt market penetration our initial products will achieve billions in forecasted sales. TTP's platform technology will lead to medicinal weight loss, tissue repair therapeutics and antibody stabilization in the near future.
Total Treatment Pharmaceuticals' technology stabilizes peptides and proteins. Our initial focus is stabilizing aqueous glucagon. With stable liquid glucagon, TTP provides a more effective solution for severe hypoglycemia with autoinjection and enables the artificial pancreas. With prompt market penetration our initial products will achieve billions in forecasted sales. TTP's platform technology will lead to medicinal weight loss, tissue repair therapeutics and antibody stabilization in the near future.